CD8A and melanoma: These inhibitory immune receptors have been previously shown to regulate antiviral and antitumor CD8+ T-cell effector function in mouse models of lymphocytic choriomeningitis virus (LCMV) and in humans with advanced melanoma (20, –, 22).